find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
351
Clinical Trials
Pediatric Oncology
Phase II
Enrolling
nct/study# NCT04301843 / BCC015
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma.
Learn More
Pediatric Oncology
Phase II
Enrolling
nct/study# NCT02679144 / BCC014
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
Learn More
Pediatric Oncology
N/A
Enrolling
nct/study# N/A / AML-BCMA
Validation of B cell maturation antigen as a biomarker for acute myeloid leukemia
Learn More
Neuro-Oncology
N/A
Enrolling
nct/study# N/A / NEURO-ONC-DATABASE
A Retrospective and Prospective Protocol to Evaluate Demographic and Clinical Outcomes in Neuro-Oncology Patients
Learn More
Neuro-Oncology
Phase III
Enrolling
nct/study# NCT06556563 / EF-41-KEYNOTE-D58
Tumor Treating Fields (TTFields) with maintenance temozolomide (TMZ) and pembrolizumab versus TTFields concomitant with maintenance TMZ and placebo in participants with newly diagnosed glioblastoma. Keynote D58
Learn More
Pediatric Oncology
Phase I/II
Enrolling
nct/study# NCT06541262 / BCC021
Phase I/II study of Silmitasertib (CX-4945) in combination withchemotherapy in children and young adults with relapsed refractory solid tumors
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.